Results 71 to 80 of about 3,819 (202)

2017 EACTS Guidelines on perioperative medication in adult cardiac surgery [PDF]

, 2017
To access publisher's full text version of this article, please click on the hyperlink in Additional Links field or click on the hyperlink at the top of the page marked FilesAstraZeneca Boheringer Ingelheim Abbvie Octapharma Orion ...
Castella, Manuel, Collet, Jean-Philippe, Dunning, Joel, Gudbjartsson, Tómas, Head, Stuart J, Jeppsson, Anders, Landmesser*, Ulf, Landoni, Giovanni, Linker, Nick J, Milojevic, Milan, Sandoval, Elena, Sousa-Uva*, Miguel, Thielmann, Matthias   +12 more
core   +2 more sources

External validation of the Haemorrhage Estimate Risk in Oral anticoagulation for Mild head trauma nomogram in Hong Kong

Hong Kong Journal of Emergency Medicine, Volume 32, Issue 2, April 2025.
Abstract Objective Currently, there is no consensus among international guidelines on the management of patients with mild traumatic brain injuries (MTBIs) who are on direct oral anti‐coagulants (DOACs). Overuse of computed tomography (CT) scan of the brain results in unnecessary radiation exposure, longer waits and higher costs.
Ho Man Cheng, Jerome Lok Tsun So, Rex Pui Kin Lam, Hon Wah Ng   +3 more
wiley   +1 more source

Successful intravenous thrombolysis for ischemic stroke after reversal of dabigatran anticoagulation with idarucizumab: a case report

Journal of Medical Case Reports, 2017
Background Non-vitamin K antagonist oral anticoagulants, including dabigatran, are currently widely used for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Sergio Agosti, Laura Casalino, Enrico Rocci, Gabriele Zaccone, Eugenia Rota   +4 more
doaj   +1 more source

Management of major bleeding in patients treated with direct oral anticoagulants: from experience to standardized protocols

Italian Journal of Medicine, 2020
Evaluation of clinical-laboratory-therapeutic management and related clinical outcomes (thrombotic-hemorrhagic complications) of patients undergoing treatment with direct oral anticoagulants (DOACs) during major bleeding. This is a two-year observational
Sara Mascia, Anna Maria Ferrari, Nicola Macarone Palmieri, Elisa Romagnoli, Chiara Catena, Serena Scarabottini, Francesca Mori, Lucio Brugioni   +7 more
doaj   +1 more source

Non-Vitamin K Oral Anticoagulants Associated Bleeding and Its Antidotes [PDF]

Journal of Stroke, 2018
Oral anticoagulant-associated intracerebral hemorrhage (OAC-ICH) accounts for nearly 20% of all ICH. The number of patients with an indication for oral anticoagulant therapy (OAT) increases with increasing age.
Thorsten Steiner, Martin Köhrmann, Peter D. Schellinger, Georgios Tsivgoulis   +3 more
doaj   +1 more source

Best practice in the management of benign prostatic hyperplasia in the patients requiring anticoagulation [PDF]

, 2018
In today's aging population, urologists are often treating older patients with multiple comorbidities. Lower urinary tract symptoms from benign prostate hyperplasia (LUTS/BPH) is a common condition that affects men, with increasing prevalence as men age.
Heiman, Joshua, Krambeck, Amy, Large, Tim   +2 more
core   +1 more source

Association of Anaesthetists guidelines: the use of blood components and their alternatives

Anaesthesia, Volume 80, Issue 4, Page 425-447, April 2025.
Summary Background The administration of blood components and their alternatives can be lifesaving. Anaemia, bleeding and transfusion are all associated with poor peri‐operative outcomes. Considerable changes in the approaches to optimal use of blood components and their alternatives, driven by the findings of large randomised controlled trials and ...
Akshay Shah, Andrew A. Klein, Seema Agarwal, Andrew Lindley, Aamer Ahmed, Kerry Dowling, Emma Jackson, Sumit Das, Divya Raviraj, Rachel Collis, Anna Sharrock, Simon J. Stanworth, Paul Moor   +12 more
wiley   +1 more source

Reversal of Dabigatran with Idarucizumab in Acute Subarachnoid Hemorrhage

Clinical Practice and Cases in Emergency Medicine, 2017
Dabigatran etexilate mesylate is a direct thrombin inhibitor used for reducing the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
Jonathan Balakumar, Ruben Santiago, Mark Supino   +2 more
doaj   +1 more source

Successful intravenous thrombolysis in acute ischemic stroke after reversal of dabigatran etexilate with idarucizumab at the end of therapeutic time window

Turkish Journal of Emergency Medicine, 2020
Dabigatran is a direct oral anticoagulant that is widely used for stroke prevention in patients with atrial fibrillation. We report a case of an 80-year-old stroke patient on dabigatran for permanent atrial fibrillation, who presented with an initial ...
Gorana Vukorepa, Sabina Deveđija*, Miljenko Crnjaković, Mirna Karakaš, Zeljka Cuk   +4 more
doaj   +1 more source

Design of small-molecule active-site inhibitors of the S1A family proteases as procoagulant and anticoagulant drugs [PDF]

, 2017
Vitamin K antagonists (VKA) have long been the default drugs for anticoagulant management in venous thrombosis. While efficacious, they are difficult to use due to interpatient dose–response variability and the risks of bleeding.
Banner D. W., Bode W., Budovich A., Cool D. E., Fritz H., Giansily-Blaizot M., Himber J., Mather T., Peter M. Fischer, Sun W. Y.   +9 more
core   +2 more sources